Invus Global Management, LLC 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-04 2:39 pm Sale | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | Invus Global Management, LLC | 5,657,105 4.000% | -2,508,269 (-30.72%) | Filing |
| 2026-02-13 11:47 am Purchase | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | Invus Global Management, LLC | 8,165,374 6.100% | 2,282,186 (+38.79%) | Filing |
| 2025-09-22 5:22 pm Purchase | 2025-09-19 | 13G | TANGO THERAPEUTICS INC TNGX | Invus Global Management, LLC | 5,883,188 5.300% | 5,883,188 (New Position) | Filing |